Fiorina; Paolo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fiorina; Paolo.The latest application filed is for "prevention and treatment of diabetic nephropathy".

Company Profile

6.7.16

Fiorina; Paolo - Boston MA
FIORINA; Paolo - Milan IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the ATP/P2X7R axis) Grant 11,452,781 - Fiorina , et al. September 27, 2	2022-09-27
Prevention And Treatment Of Diabetic Nephropathy App 20220184009 - FIORINA; Paolo ; et al.	2022-06-16
Prevention and treatment of diabetic nephropathy Grant 11,291,641 - Fiorina , et al. April 5, 2	2022-04-05
Antibodies And Uses Thereof App 20210388072 - FIORINA; Paolo ; et al.	2021-12-16
Inhibitor of IGFBP3/TMEM219 Axis and Diabetes App 20210169973 - D'Addio; Francesca ; et al.	2021-06-10
Inhibitor of IGFBP3/TMEM219 axis and diabetes Grant 11,020,453 - D'Addio , et al. June 1, 2	2021-06-01
Treatment Of Type 1 Diabetes And Autoimmune Diseases Or Disorders App 20200332258 - FIORINA; Paolo ; et al.	2020-10-22
Inhibitors Of Igfbp3 Binding To Tmem219 For Treatment Of Intestinal Diseases App 20200316168 - D'Addio; Francesca ; et al.	2020-10-08
PD-L1 expressing hematopoietic stem cells and uses Grant 10,751,373 - Fiorina A	2020-08-25
Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseases Grant 10,682,391 - D'Addio , et al.	2020-06-16
Pd-l1 Expressing Hematopoietic Stem Cells And Uses App 20200129559 - Fiorina; Paolo	2020-04-30
Cells With Increased Immuno-regulatory Properties And Methods For Their Use And Manufacture App 20200102540 - Fiorina; Paolo	2020-04-02
Pd-l1 Expressing Hematopoietic Stem Cells And Uses App 20200085878 - Fiorina; Paolo	2020-03-19
PD-L1 expressing hematopoietic stem cells and uses Grant 10,517,899 - Fiorina Dec	2019-12-31
Prevention And Treatment Of Diabetic Nephropathy App 20190224148 - FIORINA; Paolo ; et al.	2019-07-25
Method Of Preventing And Treating Type 1 Diabetes, Allograft Rejection And Lung Fibrosis (by Targeting The Atp/p2x7r Axis) App 20190184027 - FIORINA; Paolo ; et al.	2019-06-20
Pd-l1 Expressing Hematopoietic Stem Cells And Uses App 20190099450 - Fiorina; Paolo	2019-04-04
Method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the ATP/P2X7R axis) Grant 10,071,167 - Fiorina , et al. September 11, 2	2018-09-11
Inhibitor of IGFBP3/TMEM219 Axis and Diabetes App 20180243367 - D'Addio; Francesca ; et al.	2018-08-30
Pd-l1 Expressing Hematopoietic Stem Cells And Uses App 20180214487 - Fiorina; Paolo	2018-08-02
Inhibitor of IGFBP3/TMEM219 Axis and Diabetes App 20180169184 - D'Addio; Francesca ; et al.	2018-06-21
Igfbp3 And Uses Thereof App 20180172708 - D'Addio; Francesca ; et al.	2018-06-21
Method Of Preventing And Treating Type 1 Diabetes, Allograft Rejection And Lung Fibrosis (by Targeting The Atp/p2x7r Axis) App 20160067348 - FIORINA; Paolo ; et al.	2016-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.